Title : The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation.

Pub. Date : 2012 Apr 26

PMID : 21927021






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation. Cisplatin checkpoint kinase 1 Homo sapiens
2 A determinant of CDDP sensitivity in OVCA, p53, is activated by checkpoint kinase 1 (Chk1) in response to DNA damage. Cisplatin checkpoint kinase 1 Homo sapiens
3 A determinant of CDDP sensitivity in OVCA, p53, is activated by checkpoint kinase 1 (Chk1) in response to DNA damage. Cisplatin checkpoint kinase 1 Homo sapiens
4 Our findings establish for the first time that PPM1D confers CDDP resistance in OVCA cells through attenuating CDDP-induced, Chk1-mediated, p53-dependent apoptosis. Cisplatin checkpoint kinase 1 Homo sapiens
5 Our findings establish for the first time that PPM1D confers CDDP resistance in OVCA cells through attenuating CDDP-induced, Chk1-mediated, p53-dependent apoptosis. Cisplatin checkpoint kinase 1 Homo sapiens